Pathologic and Molecular Responses to Neoadjuvant Trastuzumab And/or Lapatinib from a Phase II Randomized Trial in HER2-positive Breast Cancer (TRIO-US B07)
Nature Communications（2020）
Key words
Breast cancer,Targeted therapies,Science,Humanities and Social Sciences,multidisciplinary
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined